| Literature DB >> 34732803 |
Wonwoo Lee1, In Kyung Min2, Kwang Ik Yang3, Daeyoung Kim4, Chang-Ho Yun5, Min Kyung Chu6.
Abstract
Migraine neither presents with a definitive single symptom nor has a distinct biomarker; thus, its diagnosis is based on combinations of typical symptoms. We aimed to identify natural subgroups of migraine based on symptoms listed in the diagnostic criteria of the third edition of the International Classification of Headache Disorders. Latent class analysis (LCA) was applied to the data of the Korean Sleep-Headache Study, a nationwide population-based survey. We selected a three-class model based on Akaike and Bayesian information criteria and characterized the three identified classes as "mild and low frequency," "photophobia and phonophobia," and "severe and high frequency." In total, 52.0% (65/125) of the participants were classified as "mild and low frequency," showing the highest frequency of mild headache intensity but the lowest overall headache frequency. Meanwhile, "photophobia and phonophobia" involved 33.6% (42/125) of the participants, who showed the highest frequency of photophobia and phonophobia. Finally, "severe and high frequency" included 14.4% (18/125) of the participants, and they presented the highest frequency of severe headache intensity and highest headache frequency. In conclusion, LCA is useful for analyzing the heterogeneity of migraine symptoms and identifying migraine subtypes. This approach may improve our understanding of the clinical characterization of migraine.Entities:
Mesh:
Year: 2021 PMID: 34732803 PMCID: PMC8566532 DOI: 10.1038/s41598-021-01107-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Model selection criteria for latent class analysis.
| Number of latent classes | 2 | 3 | 4 |
|---|---|---|---|
| AIC | 1453 | 1448 | 1447 |
| BIC | 1524 | 1556 | 1592 |
AIC Akaike information criterion, BIC Bayesian information criterion.
Sociodemographic, anthropometric and metabolic characteristics of participants with migraine.
| Total (n = 125) | Class 1 (n = 65) | Class 2 (n = 42) | Class 3 (n = 18) | P-value | |
|---|---|---|---|---|---|
| 45.8 ± 15.0 | 45.8 ± 15.9 | 45.3 ± 13.6 | 46.8 ± 15.8 | 0.934 | |
| 0.137 | |||||
| Male | 50 (40.0%) | 23 (35.9%) | 16 (38.1%) | 11 (61.1%) | |
| Female | 75 (60.0%) | 42 (64.6%) | 26 (61.9%) | 7 (38.9%) | |
| 0.223 | |||||
| Middle school or lower | 16 (12.8%) | 11 (16.9%) | 5 (11.9%) | 0 (0.0%) | |
| High school | 52 (41.6%) | 23 (35.4%) | 18 (42.9%) | 11 (61.1%) | |
| College or higher | 57 (45.6%) | 31 (47.7%) | 19 (45.2%) | 7 (38.9%) | |
| 22.60 (21.22, 23.64) | 22.63 (21.02, 24.08) | 22.12 (21.28, 22.95) | 22.76 (22.55, 24.99) | 0.276 | |
| 27 (21.6%) | 14 (21.5%) | 10 (23.8%) | 3 (16.7%) | 0.827 | |
| 13 (10.4%) | 7 (10.8%) | 6 (14.3%) | 0 (0.0%) | 0.314 | |
| 11 (8.8%) | 3 (4.6%) | 7 (16.7%) | 1 (5.6%) | 0.081 | |
Data are presented as the mean ± standard deviation, median (interquartile range), or n (%).
BMI body mass index.
Statistical method for comparison of the three groups: one-way analysis of variance for normally distributed variables; Kruskal–Wallis test for non-normally distributed variables; Chi-square or Fisher’s exact test for categorical variables.
Characteristics of headache under the diagnostic criteria of migraine in the third edition of the International Classification of Headache Disorders.
| Total (n = 125) | Class 1 (n = 65) | Class 2 (n = 42) | Class 3 (n = 18) | P-value | |
|---|---|---|---|---|---|
| 0.012†c | |||||
| Mild | 21 (16.8%) | 13 (20.0%) | 8 (19.1%) | 0 (0.0%) | |
| Moderate | 78 (62.4%) | 35 (53.9%) | 31 (73.8%) | 12 (66.7%) | |
| Severe | 26 (20.8%) | 17 (26.2%) | 3 (7.1%) | 6 (33.3%) | |
| 87 (69.6%) | 60 (92.3%) | 19 (45.2%) | 8 (44.4%) | < 0.001†ab | |
| 98 (78.4%) | 48 (73.9%) | 33 (78.6%) | 17 (94.4%) | 0.171 | |
| 59 (47.2%) | 8 (12.3%) | 33 (78.6%) | 18 (100.0%) | < 0.001†ab | |
| 112 (89.6%) | 63 (96.9%) | 31 (73.8%) | 18 (100.0%) | < 0.001†a | |
| 56 (44.8%) | 34 (52.3%) | 20 (47.6%) | 2 (11.1%) | 0.007†bc | |
| 45 (36.0%) | 1 (1.5%) | 42 (100.0%) | 2 (11.1%) | < 0.001†ac | |
| 66 (52.8%) | 22 (33.9%) | 42 (100.0%) | 2 (11.1%) | < 0.001†ac | |
Data are presented as n (%).
†Significant P-value.
aSignificant difference between Class 1 and Class 2 in multiple comparisons.
bSignificant difference between Class 1 and Class 3 in multiple comparisons.
cSignificant difference between Class 2 and Class 3 in multiple comparisons.
Clinical features not included in the diagnostic criteria of migraine in the third edition of the International Classification of Headache Disorders.
| Total (n = 125) | Class 1 (n = 65) | Class 2 (n = 42) | Class 3 (n = 18) | P-value | |
|---|---|---|---|---|---|
| | 0.83 (0.33, 3.00) | 0.50 (0.33, 2.00) | 1.00 (0.42, 4.00) | 1.50 (0.52, 7.00) | 0.030† |
| | 0.019†b | ||||
| < 2 | 75 (60.0%) | 44 (67.7%) | 22 (52.4%) | 9 (50.0%) | |
| ≥ 2, < 8 | 33 (26.4%) | 18 (27.7%) | 11 (26.2%) | 4 (22.2%) | |
| ≥ 8, < 15 | 12 (9.6%) | 1 (1.5%) | 6 (14.3%) | 5 (27.8%) | |
| ≥ 15 | 5 (4.0%) | 2 (3.1%) | 3 (7.1%) | 0 (0.0%) | |
| 300.0 (240.0, 480.0) | 300.0 (240.0, 600.0) | 300.0 (240.0, 465.0) | 240.0 (240.0, 300.0) | 0.030†b | |
| 48 (38.4%) | 13 (20.00%) | 28 (66.67%) | 7 (38.89%) | < 0.001†a | |
| 22 (17.6%) | 6 (9.23%) | 14 (33.33%) | 2 (11.11%) | 0.004†a | |
| 53.0 ± 8.9 | 51.3 ± 8.2 | 55.8 ± 10.0 | 52.3 ± 7.9 | 0.038†a | |
| 1.00 (0.00, 3.00) | 0.00 (0.00, 2.00) | 1.00 (0.00, 4.00) | 2.50 (0.25, 8.25) | 0.069 | |
| 14 (11.2%) | 3 (4.6%) | 9 (21.4%) | 2 (11.1%) | 0.018†a | |
| 24 (19.2%) | 9 (13.9%) | 9 (21.4%) | 6 (33.3%) | 0.161 | |
| 20 (16.0%) | 10 (15.9%) | 8 (19.1%) | 2 (11.1%) | 0.730 | |
| 44 (35.2%) | 16 (24.6%) | 20 (47.6%) | 8 (44.4%) | 0.035†a | |
| 3.67 (2.89, 4.33) | 3.44 (2.78, 3.89) | 3.89 (3.56, 4.44) | 3.89 (3.00, 4.17) | 0.021†a | |
| 27 (21.8%) | 14 (21.5%) | 12 (29.8%) | 1 (5.6%) | 0.127 | |
| 8.00 (5.00, 10.00) | 8.00 (5.00, 10.00) | 8.00 (5.00, 11.00) | 5.00 (4.25, 8.00) | 0.167 | |
Data are presented as the mean ± standard deviation, median (interquartile range), or n (%).
VARS Visual Analogue Rating Scale, HIT-6 Headache Impact Test-6, MIDAS Migraine Disability Assessment, GAD-7 General Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire-9, ASC-12 The 12‐item Allodynia Symptom Checklist, FSS Fatigue Severity Scale, ESS Epworth Sleepiness Scale.
†Significant P-value.
aSignificant difference between Class 1 and Class 2 in multiple comparisons.
bSignificant difference between Class 1 and Class 3 in multiple comparisons.
cSignificant difference between Class 2 and Class 3 in multiple comparisons.